ATC code - A02BD08
PolandBismuth subcitrate, tetracycline and metronidazole
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvisé Pharmaceuticals
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Allergan Pharmaceuticals International Limited
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Form: capsules, hard
Active substance Dosage bismuth potassium subcitrate 140 mg metronidazole 125 mg tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals